We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > BeyondSpring

News List

BeyondSpring Announces U.S. FDA Acceptance And Priority Review Of New Drug Application For Plinabulin And G-CSF Combination For The Prevention Of Chemotherapy-Induced Neutropenia (CIN) drugs
June 21, 2021
BeyondSpring Inc. today announced that the FDA has accepted for filing, and with Priority Review, the Company’s NDA seeking approval for use of plinabulin in combination with granulocyte colony-stimulating factor
BeyondSpring Granted Patent for Plinabulin americanpharmaceuticalreview
May 18, 2020
BeyondSpring announced the United States Patent and Trademark Office (USPTO) has granted the Company a new patent.
BeyondSpring Files for Patent Protection for Viral Infections Treatment americanpharmaceuticalreview
March 16, 2020
BeyondSpring announced the submission of a provisional U.S. patent application for its pipeline asset BPI-002, for methods of treating viral infections, including COVID-19 ...